The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway
- Author(s):
- Hart, L.M. 't; Fritsche, A.; Nijpels, G.; Leeuwen, N. van; Donnelly, L.A.; Dekker, J.M.; Alssema, M.; Fadista, J.; Carlotti, F. (0000-0001-7929-8468); Gjesing, A.P.; Palmer, C.N.A.; Haeften, T.W. van; Herzberg-Schafer, S.A.; Simonis-Bik, A.M.C.; Houwing-Duistermaat, J.J.; Helmer, Q.; Deelen, J.; Guigas, B.; Hansen, T.; Machicao, F.; Willemsen, G.; Heine, R.J.; Kramer, M.H.H.; Holst, J.J.; Koning, E.J.P. de (0000-0002-1232-7022); Haring, H.U.; Pedersen, O.; Groop, L.; Geus, E.J.C. de; Slagboom, P.E.; Boomsma, D.I.; Eekhoff, E.M.W.; Pearson, E.R.; Diamant, M.
- Published
- 2013
- Publication type
- Article / Letter to editor
- Date issued
- 2013-09-30
- Language
- English
- Is part of
- Diabetes (2013), Vol. 62, no. 9, p. 3275-3281
- hdl
- 1887/88241
- doi
- 10.2337/db13-0227